The novel artificial intelligence-based blood testing technology, DELFI successfully detected more than 80 percent of liver cancer through DNA referencing.
The novel artificial intelligence-based blood testing technology, DELFI successfully detected more than 80 percent of liver cancer through DNA referencing.